–
Apogee Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−30.7
FY23:
−93.0
FY24:
−217
FY25:
−286
(positive)
Change from FY22 to FY25
millions USD
FY22:
−30.6
FY23:
−84.0
FY24:
−217
FY25:
−284
(positive)
Change from FY22 to FY25
millions USD
FY22:
−39.8
FY23:
−84.0
FY24:
−182
FY25:
−256
(positive)
Change from FY22 to FY25
millions USD
FY22:
−39.8
FY23:
−84.0
FY24:
−182
FY25:
−256
All amounts in millions USD